December 11, 2024 - 05:47

District 1 Representative-Elect and Ketchikan native Jeremy Bynum is set to take his place on the House Finance Committee for the upcoming legislative session. Bynum, who has garnered attention for his commitment to fiscal responsibility, will be joining four other Republican members on the committee.
As a member of the House Finance Committee, Bynum will play a crucial role in shaping the state's budget and financial policies. His background in community service and local governance positions him well to address the financial needs of his constituents and the broader state.
Bynum expressed enthusiasm about the opportunity to contribute to important financial discussions that will impact the state’s economy. He aims to work collaboratively with other committee members to ensure that the financial interests of residents are prioritized. With a focus on transparency and accountability, Bynum is determined to make a positive impact during his term.
June 23, 2026 - 20:50
Bitcoin 'vulnerable to further weakness' as token tumbles amid tech routBitcoin took a sharp hit on Tuesday, falling in tandem with a broad sell-off in technology stocks that rattled global markets. The leading cryptocurrency dropped more than 5% in a single session,...
June 23, 2026 - 18:40
SpaceX stock dips below $150 debut before reboundingSpaceX`s stock took another hit on Tuesday, sliding below its initial public offering price of $150 before recovering later in the session. The sell-off extended a rough stretch for the company`s...
June 22, 2026 - 17:54
SpaceX stock tumbles 16.4%, shaving off most IPO gains since debutSpaceX shares took another sharp hit on Monday, putting the company on track for three consecutive days of losses. The steep decline has wiped out the majority of the gains the stock had racked up...
June 22, 2026 - 04:41
West Pharmaceutical Services (WST) Stock Could Be 6.9% Undervalued on GLP 1 Growth NarrativeWest Pharmaceutical Services (WST) stock has drawn attention after recent share price moves, with investors weighing its role in drug containment and delivery in relation to current valuation...